May 5, 2026 | Pharma, healthcare, patient access
Integrated capabilities combining advanced analytics, pharmacy, and specialized talent to improve access, affordability, and adherence

Inizio announced the official launch of its fully integrated, end-to-end Hub Services, a cornerstone of its market-leading Patient Solutions offering. Delivered by Inizio Engage, the Inizio business unit specializing in patient engagement and support, this next-generation solution addresses the growing complexity of patient access, reimbursement, and adherence, while enabling clients to partner with a more agile, strategic, and outcome-driven organization.
As life sciences organizations navigate an increasingly dynamic policy and payer landscape, and higher expectations from patients, the need for more connected, patient-centric support models has never been greater. “Inizio Engage’s evolved Hub Services introduces a next-generation approach, integrating human expertise, intelligent technology, and pharmacy capabilities, supported by advanced analytics to simplify and accelerate the path to therapy,” said Ryan Quigley, CEO, Inizio. “This launch represents another opportunity for Inizio to lead the way as the global Intelligent Commercialization partner, bringing together insight, innovation, and execution to deliver more coordinated, patient-centered solutions for our clients.”
Read full article here.
This content was provided by Inizio
Latest Content from Inizio
What does the future hold for the US pharma industry?
Pharmaceutical market research is still evolving in many emerging markets and so finding the insights you require can be a challenge.
Pharma companies are increasingly looking for ways to provide “beyond the pill” services to support patients with the management of their disease. Adherence tools and programs encourage patients to stay compliant with their treatment…
Treatment initiation is a key focus for many pharma companies as part of their strategy to increase script writing and drive greater revenues.
One of the most consistent issues researchers face with segmentation is ensuring that it is actionable.
Exploring the opportunities for pharma in the ASEAN region and factors to consider when conducting healthcare market research.
Understanding the opportunities for biosimilars and the threats to innovator biologics
The Chinese healthcare market is experiencing a period of great change. Utilising local knowledge and detailed case studies, this webinar examines the likely impact on the patient journey and considers…
Utilising the benefits of mobile technology
Presenting a window on the world of your customer
